<DOC>
	<DOCNO>NCT02184689</DOCNO>
	<brief_summary>The aim study assess efficacy safety oral regimen fexinidazole ( daily 10 day ) treatment stage 1 stage 2 T.b . gambiense sleep sickness child least 6 year old 20 kg bodyweight .</brief_summary>
	<brief_title>Efficacy Safety Fexinidazole Children Least 6 Years Old Weighing Over 20 kg With Human African Trypanosomiasis ( HAT ) Due T.b . Gambiense : Prospective , Multicentre , Open Study , plug-in Pivotal Study</brief_title>
	<detailed_description />
	<mesh_term>Trypanosomiasis , African</mesh_term>
	<mesh_term>Trypanosomiasis</mesh_term>
	<criteria>Informed consent form sign one parent child 's legal representative Child assent participate study collect presence impartial witness Age 6 15 year old &gt; 20 Kg bodyweight Boy girl Able ingest least one complete meal per day ( least one Plumpy'Nut® sachet ) Able swallow 600mg fexinidazole tablet Karnofsky index &gt; 50 Presence trypanosomes blood and/or lymph and/or CSF Permanent address ability comply followup visit schedule Child refusing include trial Bodyweight &lt; 20 Kg Severe malnutrition , define BMI 16 ( 2 Zscore norm accord WHO 2007 Growth reference data ) Inability take oral medication Pregnancy breastfeed Clinically relevant medical condition HAT , Investigator 's opinion , may jeopardize subject safety interfere participation study , include limited significant liver cardiovascular disease , active document suspected infection , central nervous system ( CNS ) trauma seizure disorder , coma alter consciousness Severely deteriorate general condition , cardiovascular shock , respiratory distress , terminal illness Any medical condition ( except HATspecific symptom ) hinder communication Investigator require completion study Any contraindication imidazole product ( know hypersensitivity imidazole ) History HAT treatment past 2 year Patients previously enrol study already receive fexinidazole . Expected followup difficulty ( migrant , refugee , itinerant vendor , etc. ) . Current alcohol drug abuse Clinically significant abnormal laboratory finding , include ASAT and/or ALAT &gt; 2 time ULN // Total bilirubin &gt; 1.5 time ULN // Severe leukopenia ( &lt; 2000/mm3 ) // Potassium ( K+ ) &lt; 3.5 mmol // Any clinically significant abnormal laboratory value ( see detail Investigator Manual ) Pregnancy confirm positive urine pregnancy test obtain within 24 hour ( h ) prior start study treatment ( see Section 5.8.3 Contraception ; p36 ) girls 12 year old ECG abnormality assess central cardiologist QTcF≥ 450 m , measure automatically ( first measurement abnormal , second assessment do least 1020 min later , patient rest position ) . Patients test malaria and/or treat adequately infection Patients treat adequately soil transmit helminthic disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>